Drugs Flashcards

1
Q

Gold risk in rheumatology

A
  • myelosupression
  • renal toxicity
  • mouth ulcer
  • photosensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MAO inhibitors side effects

A

Hypertensive reaction to foods high in tyramine (cheese, processed meats…)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drugs cause delirium

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Labetalol risks

A
  • hypoglycaemia
  • bradycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanism of ACE inhibitors

A

inhibits the conversion angiotensin I to angiotensin II
→ decrease in angiotensin II levels → to vasodilation and reduced blood pressure
→ decrease in angiotensin II levels → reduced stimulation for aldosterone release → decrease in sodium and water retention by the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

renoprotective mechanism ACE inhibitors

A

angiotensin II constricts the efferent glomerular arterioles
ACE inhibitors therefore lead to dilation of the efferent arterioles → reduced glomerular capillary pressure → decreased mechanical stress on the delicate filtration barriers of the glomeruli
this is particularly important in diabetic nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are ACE inhibitors are activated

A

phase 1 metabolism in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Side effects of ACE inhibitors

A
  • cough
  • angioedema
  • hyperkalmeia
  • first dose hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACE inhibitors cautions and contradictions

A

pregnancy and breastfeeding - avoid
renovascular disease - may result in renal impairment
aortic stenosis - may result in hypotension
hereditary of idiopathic angioedema
specialist advice should be sought before starting ACE inhibitors in patients with a potassium >= 5.0 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Interactions of ACE inhibitors

A

patients receiving high-dose diuretic therapy (more than 80 mg of furosemide a day)
significantly increases the risk of hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanism of Adenosine

A

causes transient heart block in the AV node

agonist of the A1 receptor in the atrioventricular node, which inhibits adenylyl cyclase thus reducing cAMP and causing hyperpolarization by increasing outward potassium flux

adenosine has a very short half-life of about 8-10 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adverse effects adenosine

A

chest pain
bronchospasm
transient flushing
can enhance conduction down accessory pathways, resulting in increased ventricular rate (e.g. WPW syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Contradictions of Adenosine

A

Asthmatics
Causes bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Adenosine should ideally be infused

A

large-calibre cannula due to it’s short half-life,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Interactions of adenosine

A

dipyridamole (antiplatelet agent) and blocked by theophyllines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Noticible adverse effects ADP receptor inhibitors

A

ticagrelor may cause dyspnoea
due to the impaired clearance of adenosine

17
Q

Clopidogrel contradictions

A

clopidogrel and proton pump inhibitors, particularly omeprazole and esomeprazole, leading to reducing antiplatelet effects.

18
Q

contraindications to prasugrel use.

A

prior stroke or transient ischaemic attack, high risk of bleeding, and prasugrel hypersensitivity are absolute contraindication

19
Q

Salbutamol

A
  • beta receptor agonist
  • short-acting bronchodilator
  • Relaxes bronchial smooth muscles through beta 2 receptors
20
Q

Corticosteroids

A
  • Anti-inflammatory
  • used as maintenance therapy
21
Q

Ipratropium

A
  • Blocks the muscarinic acetylcholine receptors
  • Short-acting inhaled bronchodilator. Relaxes bronchial smooth muscle
    • Used primarily in COPD
    • Tiotropium has similar effects but is long-acting
22
Q

Methylxanthines (e.g. theophylline)

A
  • Non-specific inhibitor of phosphodiesterase resulting in an increase in cAMP
  • Given orally or intravenously
    • Has a narrow therapeutic index
23
Q

Monteleukast, zafirlukast

A
  • Blocks leukotriene receptors
  • Usually taken orally
    • Useful in aspirin-induced asthma
24
Q

Oxygen saturation targets
acutely ill patients

A

94-98%

25
Q

Oxygen saturation targets patients at risk of hypercapnia (e.g. COPD patients)

A

88-92%

26
Q

COPD management O2

A

prior to availability of blood gases, use a 28% Venturi mask at 4 l/min and aim for an oxygen saturation of 88-92% for patients with risk factors for hypercapnia but no prior history of respiratory acidosis
adjust target range to 94-98% if the pCO2 is normal

27
Q

When not to use O2 therapy (no hypoxia present, but conditions diagnoses)

A

myocardial infarction and acute coronary syndromes
stroke
obstetric emergencies
anxiety-related hyperventilation

28
Q

Theophylline poisoning

A

acidosis, hypokalaemia
vomiting
tachycardia, arrhythmias
seizures

29
Q

Management of theophylline poisoning

A
  • consider gastric lavage if <1 hour prior to ingestion
    activated charcoal
  • whole-bowel irrigation can be performed if theophylline is sustained release form
    charcoal haemoperfusion is preferable to haemodialysis
30
Q

Potential mechanism of theophylline

A

theophyllines may be a non-specific inhibitor of phosphodiesterase resulting in an increase in cAMP. Other proposed mechanisms include antagonism of adenosine and prostaglandin inhibition

31
Q

canakinumab

A
  • monoclonal antibody targeted at IL-1 beta
  • used systemic juvenile idiopathic arthritis and adult-onset Still’s disease
32
Q

anakinra

A
  • IL-1 receptor antagonist
  • used in the management of rheumatoid arthritis